Stock data
AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV) reported revenue of US$61.16B and net income of US$4.23B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$61.16B | — | US$15.07B | US$4.23B | — |
| 2024 | US$56.33B | — | US$9.14B | US$4.28B | — |
| 2023 | US$54.32B | — | US$12.76B | US$4.86B | — |
| 2022 | US$58.05B | — | US$18.12B | US$11.84B | — |
| 2021 | US$56.20B | — | US$17.92B | US$11.54B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$16.99B | US$3.61B | — |
| 2026-03-31 | US$15.00B | US$695.00M | — |
| 2025-12-31 | US$16.62B | US$1.82B | — |
| 2025-09-30 | US$15.78B | US$186.00M | — |
| 2025-06-30 | US$15.42B | US$938.00M | — |
| 2025-03-31 | US$13.34B | US$1.29B | — |
| 2024-12-31 | US$15.10B | -US$22.00M | — |
| 2024-09-30 | US$14.46B | US$1.56B | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.